Catching "Early" COPD - The Diagnostic Conundrum.

Area of Science:

• Pulmonary Medicine
• Respiratory Research
• Disease Pathophysiology

Background:

• Chronic obstructive pulmonary disease (COPD) is a major global health burden with limited disease-modifying therapies.
• A poor understanding of early disease mechanisms hinders therapeutic advancements.
• Current diagnostic approaches often identify COPD only after substantial lung damage has occurred.

Purpose of the Study:

• To review the challenges in defining and identifying early chronic obstructive pulmonary disease (COPD).
• To explore insights into early disease from existing COPD studies, noting limitations in participant selection.
• To discuss promising methods for early COPD detection and potential biomarkers.

Main Methods:

• Literature review focusing on the definition and detection of early COPD.
• Analysis of existing COPD studies regarding the inclusion of at-risk populations (e.g., young smokers, mild disease).
• Evaluation of clinical measures including symptom assessment, physiological testing, and CT imaging for early detection.

Main Results:

• Defining and detecting early COPD is complex, often diagnosed late.
• Many studies lack representation of individuals at high risk or with mild disease.
• Symptom assessment, lung function tests, and CT scans show promise for early detection.
• Neutrophils and their proteinases are emerging as potential biomarkers for early COPD pathophysiology.

Conclusions:

• Early identification of COPD is beneficial but currently difficult.
• Future research should prioritize studying the earliest stages of COPD to understand initiation.
• Focusing on early disease manifestations will help identify novel therapeutic targets for COPD.